2nd Feb 2005 09:31
Lazard & Co., Ltd (Panmure Gordon)02 February 2005 EMM DISCLOSURE FORM 38.5 (SUMMARY) Lodge with a RIS and the Takeover Panel. Use a separate form for each class ofsecurities in which dealings have been made. CONNECTED EXEMPT MARKET- MAKERS:DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Name of EMM Lazard & Co., Limited (Panmure Gordon) Date of disclosure 2 February 2005 Contact name Tom Forcier Telephone number 020 7187 2252 Please see attached disclosure of dealings under Rule 38.5 in the securitiesof the following companies: Oxford BioMedica Plc AMENDMENT If the attached Rule 38.5 disclosure is to amend a previous disclosure, pleasestate which element(s) of previous disclosure was incorrect: In the case of option business or dealings in derivatives full details should begiven on a separate sheet so that the nature of the dealings can be fullyunderstood. For options this should include the number of securities underoption, the exercise period (or in the case of exercise, the exercise date), theexercise price and any option money paid or received. For derivatives thisshould include, at least, the number of reference securities to which theyrelate (when relevant), the maturity date (or if applicable the closing outdate) and the reference price. For full details of the disclosure requirements see Rules 8 and 38 of the Code.If in doubt contact the Monitoring Section of the Panel, Tel. No: 020 7638 0129.Email: [email protected] FORM 38.5CONNECTED EXEMPT MARKET-MAKERS:DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Dealing in (name of company) Oxford BioMedica Plc Class of security Ordinary shares Date of disclosure 2 February 2005 Date of dealing 1 February 2005 Name of EMM Lazard & Co., Limited (Panmure Gordon) Name of offeree/offeror with whom connected Oxford BioMedica plc Total number of securities purchased 661,502 Highest price paid* 24.5p Lowest price paid* 23.5p Total number of securities sold 500,000 Highest price received* 24.048p Lowest price received* 24.048p *Currency must be stated This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Oxford Biomedica